menu
    • menu

    Company profile for Fennec Pharmaceuticals

    Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.

    Virtual Booth

    Contact Supplier

    With Virupaksha, you get a quality product with on-time delivery.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2025-11-24

    Virtual Booth

    Contact Supplier

    Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

    Virtual Booth

    Contact Supplier

    ChemExpress delivers end-to-end CRO & CDMO solutions for small molecules, biologics & new modalities with ICH-grade quality.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Fennec Pharmaceuticals is a small stage biotechnology company focused on the development of PEDMARK TM (a unique formulation of Sodium Thiosulfate) for the prevention of ototoxicity from cisplatin in pediatric patients.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Fennec PharmaceuticalsUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    PO Box 13628 68 TW Alexander Drive Research Triangle Park, NC 27709
    Telephone
    Telephone
    919-636-4530
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://fennecpharma.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/FennecPharma

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    DDL Conference

    Not Confirmed

    envelop Contact Supplier

    DDL Conference

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Fennec Pharma Joins Piper Sandler Healthcare Conference
    Fennec Pharma Joins Piper Sandler Healthcare Conference

    26 Nov 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/11/26/3194957/0/en/Fennec-Pharmaceuticals-to-Participate-in-Piper-Sandler-37th-Annual-Healthcare-Conference.html

    GLOBENEWSWIRE
    26 Nov 2025
    Share Share
    Fennec Pharma Completes Full Debt Redemption
    Fennec Pharma Completes Full Debt Redemption

    19 Nov 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/11/19/3190807/0/en/Fennec-Pharmaceuticals-Announces-Completion-Of-Full-Debt-Redemption.html

    GLOBENEWSWIRE
    19 Nov 2025
    Share Share
    Fennec Pharma Closes Private Common Share Offering In Canada
    Fennec Pharma Closes Private Common Share Offering In Canada

    18 Nov 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/11/18/3190030/0/en/Fennec-Pharmaceuticals-Announces-Closing-of-Private-Offering-of-Common-Shares-in-Canada.html

    GLOBENEWSWIRE
    18 Nov 2025
    Share Share
    Fennec Pharma Closes Common Shares Offering
    Fennec Pharma Closes Common Shares Offering

    17 Nov 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/11/17/3189592/0/en/Fennec-Pharmaceuticals-Announces-Closing-of-Offering-of-Common-Shares.html

    GLOBENEWSWIRE
    17 Nov 2025
    Share Share
    Fennec Pharma Announces Proposed Offering of Common Shares
    Fennec Pharma Announces Proposed Offering of Common Shares

    13 Nov 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/11/13/3187861/0/en/Fennec-Pharmaceuticals-Announces-Proposed-Offering-of-Common-Shares.html

    GLOBENEWSWIRE
    13 Nov 2025
    Share Share
    Fennec Pharma Reveals Q3 2025 Financials And Business Update
    Fennec Pharma Reveals Q3 2025 Financials And Business Update

    13 Nov 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/11/13/3187800/0/en/Fennec-Pharmaceuticals-Reports-Third-Quarter-2025-Financial-Results-and-Provides-Business-Update.html

    GLOBENEWSWIRE
    13 Nov 2025
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search